Detalles de la búsqueda
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657242
2.
High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia.
Blood
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669635
3.
Quad-class exposed/refractory myeloma is associated with short survival.
Br J Haematol
; 204(1): 186-190, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833834
4.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122385
5.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Am J Hematol
; 99(3): 350-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165016
6.
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Blood
; 137(7): 877-887, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181832
7.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
J Antimicrob Chemother
; 77(9): 2546-2556, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748614
8.
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Haematologica
; 107(9): 2163-2172, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172560
9.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273476
10.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112687
11.
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
N Engl J Med
; 377(13): 1250-1260, 2017 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28953447
12.
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
Ann Hematol
; 99(6): 1341-1350, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342134
13.
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
Ann Hematol
; 99(7): 1595-1604, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417940
14.
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 20(2): 202-215, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658935
15.
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.
Biol Blood Marrow Transplant
; 25(7): 1465-1471, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928627
16.
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Biol Blood Marrow Transplant
; 25(5): 906-911, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481598
17.
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.
Cytokine
; 120: 85-87, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035172
18.
Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen.
Haematologica
; 109(1): 357-361, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470151
19.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
Ann Hematol
; 98(6): 1441-1447, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874851
20.
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Ann Hematol
; 98(6): 1435-1440, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874850